First reported 18 hours ago -
Updated 18 hours ago -
By a News Reporter-Staff News Editor at Pharma Business Week -- Mylan Inc. (Nasdaq: MYL) announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version
of Genentech's Xeloda® Tablets. Mylan received final approval from ...
[Published 4 Traders - 18 hours ago]